Growth Hormone
Tesamorelin
Synthetic research peptide modeled after growth hormone-releasing hormone (GHRH). Studied in preclinical environments for its interaction with growth hormone pathways, IGF-1 signaling, and hypothalamic-pituitary axis regulation. Research investigates how Tesamorelin may influence cellular markers associated with growth hormone secretion dynamics, peptide-receptor interaction, and downstream metabolic signaling. Existing mechanistic data arise from laboratory and animal studies.
Research Areas
- GHRH receptor interaction
- Pulsatile GH signaling
- IGF-1 pathway modulation
- Neuroendocrine regulation
- Metabolic signaling markers
- Peptide stability research
- Receptor specificity
Sold exclusively to licensed medical and clinical B2B accounts. Intended for professional use under the supervision of licensed practitioners.